Precision BioSciences, Inc. is a biotechnology company that specializes in gene editing. The company's proprietary ARCUS genome editing platform enables the production of highly specific nucleases that can insert, remove, and modify DNA at specific locations in the genome. Precision BioSciences is developing a pipeline of gene therapies for a range of diseases, including cancer, genetic disorders, and infectious diseases. The company is also collaborating with other biotechnology and pharmaceutical companies to develop gene therapies using its ARCUS platform. Precision BioSciences was founded in 2006 and is headquartered in Durham, North Carolina.